Pathstone Family Office’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Pathstone Family Office’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-575	Closed	-$20K	–	191
2015 Q4	$20K	Buy	+575	New	+$17.9K	0.09%	33
2015 Q3	–	Sell	-400	Closed	-$18K	–	181
2015 Q2	$18K	Buy	+400	New	+$15K	0.03%	66

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Pathstone Family Office's DPLO Position: Q1 2016 in Review

Pathstone Family Office sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2016, closing a stake of 575 shares — an estimated $20K sold.

Pathstone Family Office first reported a position in DPLO in Q2 2015 and held it in 2 quarters. The position peaked at $20K in Q4 2015. 160 funds tracked by Wall St. Rank hold DPLO as of Q1 2016.

Pathstone Family Office reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2016 after selling out during the quarter.
Pathstone Family Office sold 575 DIPLOMAT PHARMACY, INC. shares in Q1 2016, an estimated $20K.
Pathstone Family Office first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 2 quarters.
Pathstone Family Office's DIPLOMAT PHARMACY, INC. position peaked at $20K in Q4 2015.
160 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2016.

Based on Pathstone Family Office's 13F filing for Q1 2016, filed 12 May 2016.